| David Henry Mulholland, MD | |
|
970 Lakeland Dr, Suite 61, Jackson, MS 39216-4635 | |
| (601) 982-7850 | |
| (601) 718-5145 |
| Full Name | David Henry Mulholland |
|---|---|
| Gender | Male |
| Speciality | Cardiovascular Disease (cardiology) |
| Experience | 44 Years |
| Location | 970 Lakeland Dr, Jackson, Mississippi |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1578509501 | NPI | - | NPPES |
| 00115245 | Medicaid | MS |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RC0000X | Internal Medicine - Cardiovascular Disease | 9162 (Mississippi) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| St Dominic-jackson Memorial Hospital | Jackson, MS | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Jackson Heart Clinic. P.a. | 0547204091 | 32 |
News Archive
Scientists have discovered a dietary strategy that may address obesity by reducing endotoxemia, a major contributor to chronic, low-grade inflammation (CLGI).
Women with locally advanced cervical cancer whose treatment follows national guidelines for care have better survival, regardless of race, ethnicity or stage of cancer.
A transient ischemic attack is a form of minor stroke that can last just minutes, often without any lingering symptoms. But if left untreated, those who have one are at an estimated 25 percent greater risk of having another stroke or other complication within 90 days.
A Phase 2 trial led by City of Hope, a world-renowned research and treatment center for cancer and diabetes, suggests that adding the novel ataxia telangiectasia and Rad3-related (ATR) inhibitor drug berzosertib to standard-of-care chemotherapy for patients with metastatic urothelial cancer does not extend progression-free survival.
Dotmatics Ltd, a scientific informatics software and services company that is driving the automation of laboratory data workflows for scientific discovery and innovation research, today announced it has entered a licensing agreement with Compugen, a clinical-stage drug discovery and development company focused on immuno-oncology.
› Verified 5 days ago
| Entity Name | St. Dominic Jackson Memorial |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1235173691 PECOS PAC ID: 4385531847 Enrollment ID: O20040301000818 |
News Archive
Scientists have discovered a dietary strategy that may address obesity by reducing endotoxemia, a major contributor to chronic, low-grade inflammation (CLGI).
Women with locally advanced cervical cancer whose treatment follows national guidelines for care have better survival, regardless of race, ethnicity or stage of cancer.
A transient ischemic attack is a form of minor stroke that can last just minutes, often without any lingering symptoms. But if left untreated, those who have one are at an estimated 25 percent greater risk of having another stroke or other complication within 90 days.
A Phase 2 trial led by City of Hope, a world-renowned research and treatment center for cancer and diabetes, suggests that adding the novel ataxia telangiectasia and Rad3-related (ATR) inhibitor drug berzosertib to standard-of-care chemotherapy for patients with metastatic urothelial cancer does not extend progression-free survival.
Dotmatics Ltd, a scientific informatics software and services company that is driving the automation of laboratory data workflows for scientific discovery and innovation research, today announced it has entered a licensing agreement with Compugen, a clinical-stage drug discovery and development company focused on immuno-oncology.
› Verified 5 days ago
| Entity Name | Jackson Heart Clinic. P.a. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1659318558 PECOS PAC ID: 0547204091 Enrollment ID: O20050615000346 |
News Archive
Scientists have discovered a dietary strategy that may address obesity by reducing endotoxemia, a major contributor to chronic, low-grade inflammation (CLGI).
Women with locally advanced cervical cancer whose treatment follows national guidelines for care have better survival, regardless of race, ethnicity or stage of cancer.
A transient ischemic attack is a form of minor stroke that can last just minutes, often without any lingering symptoms. But if left untreated, those who have one are at an estimated 25 percent greater risk of having another stroke or other complication within 90 days.
A Phase 2 trial led by City of Hope, a world-renowned research and treatment center for cancer and diabetes, suggests that adding the novel ataxia telangiectasia and Rad3-related (ATR) inhibitor drug berzosertib to standard-of-care chemotherapy for patients with metastatic urothelial cancer does not extend progression-free survival.
Dotmatics Ltd, a scientific informatics software and services company that is driving the automation of laboratory data workflows for scientific discovery and innovation research, today announced it has entered a licensing agreement with Compugen, a clinical-stage drug discovery and development company focused on immuno-oncology.
› Verified 5 days ago
| Entity Name | St. Dominic Medical Associates Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1407920549 PECOS PAC ID: 0446303168 Enrollment ID: O20090728000821 |
News Archive
Scientists have discovered a dietary strategy that may address obesity by reducing endotoxemia, a major contributor to chronic, low-grade inflammation (CLGI).
Women with locally advanced cervical cancer whose treatment follows national guidelines for care have better survival, regardless of race, ethnicity or stage of cancer.
A transient ischemic attack is a form of minor stroke that can last just minutes, often without any lingering symptoms. But if left untreated, those who have one are at an estimated 25 percent greater risk of having another stroke or other complication within 90 days.
A Phase 2 trial led by City of Hope, a world-renowned research and treatment center for cancer and diabetes, suggests that adding the novel ataxia telangiectasia and Rad3-related (ATR) inhibitor drug berzosertib to standard-of-care chemotherapy for patients with metastatic urothelial cancer does not extend progression-free survival.
Dotmatics Ltd, a scientific informatics software and services company that is driving the automation of laboratory data workflows for scientific discovery and innovation research, today announced it has entered a licensing agreement with Compugen, a clinical-stage drug discovery and development company focused on immuno-oncology.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| David Henry Mulholland, MD 970 Lakeland Dr, Suite 61, Jackson, MS 39216-4635 Ph: (601) 982-7850 | David Henry Mulholland, MD 970 Lakeland Dr, Suite 61, Jackson, MS 39216-4635 Ph: (601) 982-7850 |
News Archive
Scientists have discovered a dietary strategy that may address obesity by reducing endotoxemia, a major contributor to chronic, low-grade inflammation (CLGI).
Women with locally advanced cervical cancer whose treatment follows national guidelines for care have better survival, regardless of race, ethnicity or stage of cancer.
A transient ischemic attack is a form of minor stroke that can last just minutes, often without any lingering symptoms. But if left untreated, those who have one are at an estimated 25 percent greater risk of having another stroke or other complication within 90 days.
A Phase 2 trial led by City of Hope, a world-renowned research and treatment center for cancer and diabetes, suggests that adding the novel ataxia telangiectasia and Rad3-related (ATR) inhibitor drug berzosertib to standard-of-care chemotherapy for patients with metastatic urothelial cancer does not extend progression-free survival.
Dotmatics Ltd, a scientific informatics software and services company that is driving the automation of laboratory data workflows for scientific discovery and innovation research, today announced it has entered a licensing agreement with Compugen, a clinical-stage drug discovery and development company focused on immuno-oncology.
› Verified 5 days ago
Graves Crawley Stubblefield Jr., M.D. Cardiovascular Disease Medicare: Medicare Enrolled Practice Location: 406 Briarwood Dr, Jackson, MS 39206 Phone: 601-991-1933 Fax: 601-978-3844 | |
Dr. Rebecca Chick Pace, M.D. Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 1200 N State St, Suite 500, Jackson, MS 39202 Phone: 601-352-2273 Fax: 601-714-3415 | |
Jewelian Akbar Baig, MD Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 971 Lakeland Dr Ste 356, Jackson, MS 39216 Phone: 601-200-4644 Fax: 601-200-4645 | |
Jo P Deal, MD Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 766 Lakeland Dr # A, Jackson, MS 39216 Phone: 601-368-3440 Fax: 601-368-3441 | |
Caryl P. Sumrall, FNP Cardiovascular Disease Medicare: Not Enrolled in Medicare Practice Location: 2500 North State Street, Department Of Medicine/division Of General Internal Med, Jackson, MS 39216 Phone: 601-984-5660 | |
Meghan Alford Luter, M.D. Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 2500 N State St, Jackson, MS 39216 Phone: 601-984-5532 | |
Tammy H Young, M.D. Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 1227 N State St, Ste 101, Jackson, MS 39202 Phone: 601-355-2485 Fax: 601-353-1463 |